Physician
The Regents of the University of California
The Regents of the University of California was paid $35.81M by Medicaid between Jan 2018 and Dec 2024, across 204 billing codes. Its largest line is 99233, hospital visit by a doctor, follow-up day (complex) — 21% of everything it billed.
33Billing provider infoTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
LOS ANGELES, CA 90095
LOS ANGELES, CA 90095
33aNPI1235107566assigned 03/11/2006
33bProvider typeFamily Medicine Physician
28Total paid$35.81M
24GClaims932,307
24DCodes billed204
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#10 of 2,511
Median peer was paid$13K
This provider vs. median2,787×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HALE, KATHERINE controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 92,638 | $1.80M | |
| 2019 | 103,239 | $2.88M | |
| 2020 | 103,585 | $3.59M | |
| 2021 | 141,129 | $5.55M | |
| 2022 | 131,425 | $6.09M | |
| 2023 | 166,822 | $7.84M | |
| 2024incomplete | 193,469 | $8.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 21% | 182,805 | 44,042 | $7.45M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 122,083 | 102,877 | $5.44M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 12% | 39,737 | 8,465 | $4.27M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7.8% | 44,301 | 42,399 | $2.79M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.2% | 40,782 | 35,300 | $2.58M |
| 99223 | Prolong inpt eval add15 m | 5.6% | 28,846 | 21,770 | $2.00M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.0% | 55,222 | 16,331 | $1.44M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.6% | 42,202 | 36,166 | $1.28M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3.5% | 147,426 | 107,172 | $1.26M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 11,092 | 10,738 | $744K |
| 99205 | Prolong outpt/office vis | 1.4% | 6,081 | 5,915 | $494K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.1% | 11,094 | 10,323 | $398K |
192 more codes
| 90961 | <1% | 2,594 | $337K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 5,080 | $283K |
| J0897 | Injection, denosumab, 1 mg | <1% | 305 | $258K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 7,467 | $247K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,518 | $200K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 987 | $173K |
| 99358 | Prolong nursin fac eval 15m | <1% | 3,856 | $171K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,201 | $171K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 804 | $152K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,211 | $152K |
| 93000 | <1% | 12,121 | $136K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,019 | $132K |
| 93308 | <1% | 4,749 | $120K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 1,149 | $116K |
| 99292 | <1% | 2,296 | $114K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,044 | $114K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 1,383 | $100K |
| 99220 | <1% | 1,366 | $99K | |
| 90966 | <1% | 586 | $92K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 482 | $84K |
| 99255 | <1% | 711 | $83K | |
| 20550 | <1% | 3,837 | $82K | |
| 93793 | <1% | 14,077 | $79K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 1,661 | $79K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 964 | $77K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 440 | $71K |
| 93015 | <1% | 1,452 | $70K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,253 | $67K |
| 93351 | <1% | 409 | $60K | |
| 99497 | <1% | 2,142 | $58K | |
| 93320 | <1% | 1,806 | $58K | |
| 90962 | <1% | 712 | $57K | |
| 31624 | <1% | 469 | $56K | |
| 93325 | <1% | 7,196 | $53K | |
| 20553 | <1% | 1,279 | $50K | |
| 93321 | <1% | 4,472 | $50K | |
| 99356 | <1% | 1,790 | $49K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,972 | $46K |
| 90677 | <1% | 339 | $45K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 333 | $43K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 2,170 | $43K |
| 99152 | <1% | 1,518 | $37K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 609 | $35K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 578 | $35K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 676 | $33K |
| 76937 | <1% | 3,560 | $33K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 673 | $33K |
| 99443 | <1% | 346 | $27K | |
| 43235 | <1% | 236 | $25K | |
| 94010 | <1% | 3,130 | $25K | |
| 90686 | <1% | 1,160 | $25K | |
| 94729 | <1% | 2,611 | $24K | |
| 99496 | <1% | 342 | $24K | |
| 36556 | <1% | 343 | $22K | |
| 99254 | <1% | 195 | $22K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 753 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,894 | $20K |
| 99217 | <1% | 775 | $20K | |
| 95251 | <1% | 1,229 | $19K | |
| 99226 | <1% | 494 | $19K | |
| 99000 | <1% | 4,589 | $19K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,822 | $19K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,600 | $19K |
| 93296 | <1% | 1,140 | $19K | |
| 20610 | <1% | 968 | $18K | |
| 90715 | <1% | 258 | $17K | |
| 97810 | <1% | 1,409 | $17K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,991 | $17K |
| 93248 | <1% | 1,049 | $16K | |
| 99236 | Prolong inpt eval add15 m | <1% | 200 | $15K |
| 93018 | <1% | 1,229 | $15K | |
| 99221 | <1% | 425 | $15K | |
| 99245 | <1% | 85 | $14K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 679 | $14K |
| 36410 | <1% | 1,614 | $14K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,345 | $14K |
| 93458 | <1% | 86 | $14K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 399 | $13K |
| 77080 | <1% | 482 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,794 | $12K |
| 99442 | <1% | 229 | $12K | |
| 94726 | <1% | 1,209 | $11K | |
| 93454 | <1% | 66 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,622 | $11K |
| 93295 | <1% | 231 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 220 | $10K |
| 90662 | <1% | 936 | $9K | |
| 90694 | <1% | 282 | $9K | |
| 94618 | <1% | 411 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 85 | $8K |
| 0011A | <1% | 583 | $8K | |
| 93356 | <1% | 266 | $8K | |
| 0012A | <1% | 482 | $8K | |
| 93246 | <1% | 936 | $8K | |
| 93294 | <1% | 424 | $7K | |
| 96127 | <1% | 551 | $7K | |
| 93280 | <1% | 303 | $7K | |
| 31645 | <1% | 77 | $7K | |
| 99495 | <1% | 134 | $7K | |
| 90656 | <1% | 311 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 69 | $6K |
| 0002A | <1% | 312 | $6K | |
| 0001A | <1% | 420 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 179 | $5K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 85 | $5K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 31 | $5K |
| 17110 | <1% | 73 | $4K | |
| 93298 | <1% | 116 | $4K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 13 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 91 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,042 | $4K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 30 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 413 | $3K |
| Z4306 | <1% | 60 | $3K | |
| 97139 | <1% | 419 | $3K | |
| 90480 | <1% | 235 | $3K | |
| 80053 | Comprehensive metabolic panel | <1% | 792 | $3K |
| 69209 | <1% | 289 | $3K | |
| 0296T | <1% | 278 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 53 | $3K |
| 93244 | <1% | 206 | $3K | |
| 99490 | Ccm add 20min | <1% | 156 | $2K |
| 99385 | <1% | 14 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 342 | $2K |
| 93451 | <1% | 14 | $2K | |
| 91320 | <1% | 417 | $2K | |
| 0298T | <1% | 272 | $2K | |
| 99441 | <1% | 64 | $2K | |
| 81002 | <1% | 993 | $2K | |
| 90670 | <1% | 70 | $2K | |
| 96367 | <1% | 45 | $2K | |
| 93016 | <1% | 95 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 31 | $2K |
| 99284 | Emergency room visit (serious) | <1% | 31 | $2K |
| 0031A | <1% | 83 | $1K | |
| G0406 | Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | <1% | 89 | $1K |
| 99417 | Prolong home eval add 15m | <1% | 25 | $1K |
| 93970 | <1% | 37 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,236 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 27 | $1K |
| 99498 | <1% | 17 | $996.76 | |
| 94060 | <1% | 68 | $978.34 | |
| 96523 | <1% | 64 | $909.50 | |
| 95806 | <1% | 27 | $898.31 | |
| 11102 | <1% | 13 | $894.17 | |
| 97803 | <1% | 13 | $893.71 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 31 | $760.48 |
| 99316 | <1% | 14 | $705.34 | |
| 17000 | <1% | 25 | $699.05 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 74 | $682.31 |
| 99201 | <1% | 12 | $675.66 | |
| 1111F | <1% | 3,222 | $655.49 | |
| 90732 | <1% | 25 | $652.74 | |
| 82947 | <1% | 638 | $614.38 | |
| 99307 | <1% | 46 | $583.68 | |
| 99235 | <1% | 12 | $582.58 | |
| 93242 | <1% | 75 | $520.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 48 | $438.91 |
| G0008 | Administration of influenza virus vaccine | <1% | 305 | $433.02 |
| 74328 | <1% | 12 | $427.56 | |
| 93283 | <1% | 13 | $415.38 | |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | <1% | 19 | $407.64 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 21 | $376.85 |
| 36620 | <1% | 13 | $344.45 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 67 | $324.04 |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 13 | $295.10 |
| 87400 | <1% | 58 | $212.40 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 54 | $180.00 |
| 82378 | <1% | 39 | $161.80 | |
| 99418 | Prolong nursin fac eval 15m | <1% | 62 | $158.50 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $151.05 |
| 81025 | <1% | 26 | $135.79 | |
| 0072A | <1% | 13 | $120.00 | |
| 3075F | <1% | 156 | $106.40 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 13 | $55.05 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 21 | $51.53 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 15 | $43.88 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 19 | $25.49 |
| 83615 | <1% | 16 | $21.68 | |
| 82962 | <1% | 143 | $19.16 | |
| 83037 | <1% | 66 | $7.00 | |
| 3078F | 0% | 2,126 | $0.00 | |
| 1159F | 0% | 1,533 | $0.00 | |
| 1160F | 0% | 964 | $0.00 | |
| 99072 | 0% | 400 | $0.00 | |
| 3077F | 0% | 56 | $0.00 | |
| 1126F | 0% | 2,448 | $0.00 | |
| 3079F | 0% | 401 | $0.00 | |
| 3074F | 0% | 2,197 | $0.00 | |
| 3044F | 0% | 995 | $0.00 | |
| 1125F | 0% | 199 | $0.00 | |
| 1170F | 0% | 122 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALE, KATHERINE (DIRECTOR OF ACCOUNTING)
| Provider | Location | Paid |
|---|---|---|
| Regents of the Univ of Ca Emer Med | Los Angeles, CA | $7.58M |
| Regents University of California | Santa Monica, CA | $7.36M |
| Jules Stein Eye Institute Medical Group | Los Angeles, CA | $2.16M |
| The Regents of the University of California | Los Angeles, CA | $1.72M |
| Regents of the University of California | Los Angeles, CA | $1.58M |
| Regents of the University of California | Van Nuys, CA | $611K |
| Regents of the University of California | Los Angeles, CA | $287K |
| Uc Regents | Santa Monica, CA | $231K |
| Regents of the University of California Los Angeles | Los Angeles, CA | $201K |
| The Regents of the University of California | Los Angeles, CA | $191K |
| UCLA Associated General Surgeons | Los Angeles, CA | $170K |
| The Regents of the University of California | Los Angeles, CA | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.